Cytology report categories

What Your Fluid Cytology — Report Categories Mean

A fluid cytology report categorises your sample on a five-point scale, each step carrying a different level of concern about cancer. The category is not a final diagnosis — it is a statement of probability. A negative result does not always mean cancer has been ruled out.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

Five categories, not a yes or no — The report describes the probability of cancer, not a confirmed diagnosis.
Negative is not the same as clear — Fluid cytology misses a significant proportion of cancers — a negative result must be read in context.
Two sites, two reporting systems — Chest and abdominal fluid uses the TIS system; bile duct and pancreas samples use the PSC system.
The category guides the next step — Each category has a recommended clinical pathway that your oncologist will explain.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

A fluid cytology report places your sample in one of five categories describing the probability of cancer being present, from non-diagnostic through to malignant. A result of 'negative for malignancy' means no cancer cells were found in that sample — but it does not guarantee the fluid is free of cancer.

What does each category on a fluid cytology report mean?

The International System for Reporting Serous Fluid Cytopathology — published by the International Academy of Cytology and the World Health Organization in 2020 — sets five categories for fluid sampled from the chest, abdomen, or the sac around the heart.

Each category carries a range of malignancy risk that rises from the first to the last. Your oncologist reads the category alongside your symptoms, imaging, and history — not the report in isolation.

The category also tells your team what the laboratory recommends checking next, which is why it matters beyond just the label.

What should I do when I receive this report?

Write down the exact category name or number from the report before your appointment.
Note which fluid was sampled — pleural (chest), peritoneal (abdomen), pericardial (heart sac), or biliary or pancreatic.
Ask your oncologist to explain the malignancy risk range that goes with your specific category.
Ask what the next investigation will be if this result is not conclusive.
Bring earlier scan reports and biopsy results so your team can read them alongside this one.

Can a fluid cytology report miss cancer even when the result is negative?

Yes. Fluid cytology has a real false-negative rate — cancer can be present in the fluid even when the laboratory does not find cancer cells in the sample sent.

Cancer cells may be too sparse in the fluid to appear in the volume analysed, the sample collected may be insufficient, or some tumours shed very few cells. This is not a laboratory error; it is a known limitation of the test.

The IAC/WHO 2020 reporting system builds this limitation in explicitly: 'negative for malignancy' carries a non-zero malignancy risk range, not a zero one. If clinical suspicion remains after a negative result, your oncologist may recommend a tissue biopsy rather than stopping the investigation.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

How do the two cytology reporting systems compare?

	TIS — serous fluid (IAC/WHO 2020)	PSC — pancreatobiliary
Category I	Non-diagnostic	Non-diagnostic
Category II	Negative for malignancy	Negative for malignancy
Category III	Atypia of undetermined significance	Atypical
Category IV	Suspicious for malignancy	Neoplastic (benign or other)
Category V	Malignant	Suspicious for malignancy
Category VI	—	Positive / malignant

What do the medical terms on this report mean?

Non-diagnostic: The sample did not contain enough cells, or the cells were too damaged to assess. It means the test needs to be repeated — not that the result is negative.
Negative for malignancy: No cancer cells were found in this sample. This is a reassuring result, but it does not completely rule out cancer — clinical context determines whether further investigation is needed.
Atypia of undetermined significance: The cells look slightly abnormal but not clearly cancerous. This sits in the middle of the scale and usually leads to further investigation rather than a direct treatment decision.
Suspicious for malignancy: Features strongly suggest cancer but the sample does not meet all criteria for a definitive malignant call. Tissue biopsy is almost always the recommended next step.
Malignant: Cancer cells are clearly present in the sample. This is a definitive positive result. It does not on its own identify where in the body the cancer originally started.
Risk of malignancy (ROM): The probability, expressed as a range, that a sample in a given category actually contains cancer. Built into both the TIS and PSC systems so that clinicians know how much weight to give each category result.

What do families ask most often after receiving this report?

My report says 'atypia of undetermined significance' — is that cancer?

Not definitively. Atypia means the cells look unusual but the laboratory cannot say with confidence that they are malignant. This category sits in the middle of the five-point scale and almost always leads to further investigation — usually an image-guided biopsy of the suspicious area, or a repeat fluid sample — rather than a direct treatment decision. Ask your oncologist what they are recommending next and on what timeline, so you are not left waiting without a clear plan.

My report is negative but my oncologist wants another test — why?

Because a negative fluid cytology carries a known, non-zero false-negative rate, and your oncologist is being appropriately cautious. Cancer cells may be too sparse in the fluid to appear in the portion analysed, or the tumour may shed very few cells into the fluid at all. A clinical picture that still suggests cancer — worrying symptoms, a suspicious scan, rising tumour markers — outweighs a single negative cytology. A tissue biopsy from the suspected site is more definitive than fluid cytology alone.

If it says malignant, does that mean cancer has spread?

Finding cancer cells in pleural or peritoneal fluid does indicate that cancer has reached that body cavity, which is significant staging information. However, the cytology report alone does not identify the source of the cancer, the full extent of spread, or the treatment implications. That picture comes from combining the cytology with your imaging, the biopsy from the primary tumour, and your full clinical history. Do not read a malignant cytology result in isolation — bring it to your oncologist with all of that context.

Is a fluid sample as reliable as a tissue biopsy?

No. A tissue biopsy — where a needle or surgical instrument removes a fragment of the tumour itself — provides more information and is more reliable than cells found floating in fluid. Fluid cytology is used when a tissue biopsy is not immediately possible, or as a first investigation when fluid is already being drained for symptom relief. A positive fluid result is clinically actionable. A negative result should usually be followed by tissue sampling before cancer is excluded from the diagnosis.

Can I ask for a second opinion on the cytology report?

Yes, and it is entirely reasonable — especially for a result in the atypical or suspicious category, or where there is genuine uncertainty. Difficult cytology cases are routinely discussed at tumour board meetings or referred to specialist laboratories. If your report was prepared by a general laboratory and the result sits in a middle category, asking for review by a cytopathologist with specialist experience in this site or fluid type is a fair and appropriate request that any responsible oncologist should support.

Explore 114 more Waiting For and Understanding Your Report topics

Cytology Reporting Systems

Gleason & Prostate Biopsy Reporting

Grade, Differentiation & Mitotic Index

Margins, LVI and PNI

Reading Your Histopathology Report

Staging on a Biopsy Report

Waiting for Results

All Waiting For and Understanding Your Report →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

What is the difference between pleural fluid cytology and a pleural biopsy?

Cytology examines cells that have shed into the fluid. A biopsy removes a small fragment of the pleural lining directly. Biopsy gives more tissue, is more sensitive — particularly for mesothelioma — and can provide material for molecular testing that fluid cytology cannot. Cytology is less invasive and can be done while fluid is being drained for symptom relief. A negative cytology in a patient with strong clinical suspicion is one of the most common reasons a biopsy is then recommended.

How long does a fluid cytology result usually take?

A standard cytology result usually takes three to seven working days from when the laboratory receives the sample. If immunohistochemistry stains are needed — to identify what type of cancer is present — it can take longer, sometimes up to two weeks. Ask the team who took the sample when results are expected and who will contact you, so you are not waiting without a clear timeline or a name to follow up with.

What does it mean if the report mentions 'mesothelial cells'?

Mesothelial cells line the chest and abdominal cavities, so finding them in fluid is normal and does not on its own indicate cancer. Their presence is a routine comment. However, abnormal or reactive mesothelial cells can appear with inflammation or, in some cases, with mesothelioma. Your cytopathologist will comment specifically on their features if they are relevant to the overall assessment. The phrase 'mesothelial cells present' alone is not a finding that requires action.

What is pancreatobiliary cytology and how is it different from pleural cytology?

Pancreatobiliary cytology refers to samples taken from the bile duct or pancreas, usually during an ERCP or an endoscopic ultrasound with fine-needle aspiration. These use the PSC reporting system rather than the TIS system used for serous fluids, and the PSC system has six categories rather than five. The risk ranges and recommended next steps also differ because the anatomy, access method, and cancer types encountered are different from those seen in pleural or peritoneal fluid.

What happens after a suspicious or malignant cytology result?

A malignant fluid result typically leads to staging scans, immunohistochemistry to establish the cancer type, and a multidisciplinary team discussion about treatment. A suspicious result usually leads to tissue biopsy to confirm before treatment planning begins. The exact pathway depends on your cancer type, the site, and the clinical picture. Ask specifically what investigation is happening next and when you can expect that result — you should leave the appointment with both of those answers.

Can fluid cytology show whether treatment is working?

No. Fluid cytology is a diagnostic test, not a monitoring tool. Treatment response is assessed through imaging — typically CT scanning, sometimes PET-CT coordinated with a partner imaging centre — and through clinical assessment. If fluid reaccumulates during treatment, a new cytology sample may contribute to decision-making in that situation. But a single cytology result cannot tell you whether a tumour has responded to a drug, and it is not used for that purpose.

Full index